MedPath

GEN-CLOZAPINE

GEN-CLOZAPINE

Approved
DIN Number

02554682

Drug Class

Human

Market Date

May 29, 2025

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02554682
AIG Number0122583004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AH02 CLOZAPINE
Product Specifications
Dosage FormTablet (Orally Disintegrating)
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLOZAPINEActive
Strength: 200 MG
Monograph: CLOZAPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.